Diabetes & Metabolism Journal

Skip Navigation: Skip to contents

: Search

Home
Current
- Current issue
- Ahead-of print
Browse
Collections
For contributors
- For Authors
- Instructions for authors
- Article processing charge
- e-submission
- For Reviewers
- Instructions for reviewers
- How to become a reviewer
- Best reviewers
- For Readers
- Readership
- Subscription
- Permission guidelines
About
Editorial policy
E-Submission

OPEN ACCESS

mobile menu button

Current
- Current issue
- Ahead-of print
Browse
Collections
For contributors
- For Authors
- Instructions for authors
- Article processing charge
- e-submission
- For Reviewers
- Instructions for reviewers
- How to become a reviewer
- Best reviewers
- For Readers
- Readership
- Subscription
- Permission guidelines
About
Editorial policy

Search

Page Path: HOME > Search

Letter

Letter: Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019:43:711–7): Dimitrios Patoulias, Michael Doumas; Diabetes Metab J. 2019;43(6):906-908. Published online December 26, 2019; DOI: https://doi.org/10.4093/dmj.2019.0107

3,076 View
46 Download

PDF PubReader

First
Prev
Page of 1
Next
Last

ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
- For Authors
- Instructions for authors
- Article processing charge
- e-submission
- For Reviewers
- Instructions for reviewers
- How to become a reviewer
- Best reviewers
- For Readers
- Readership
- Subscription
- Permission guidelines

Email address

Sign up for the DMJ newsletter—
what matters in science, free to your inbox daily.

TOP